How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy

• Egile Nagusiak: Paolo Spallarossa (Egilea), Matteo Sarocchi (Egilea), Giacomo Tini (Egilea), Eleonora Arboscello (Egilea), Matteo Toma (Egilea), Pietro Ameri (Egilea), Italo Porto (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2020-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Immune-checkpoint inhibitors (ICIs) represent a successful paradigm in the treatment of cancer. ICIs elicit an immune response directed against cancer cells, by targeting the so-called immune checkpoints, key regulators of the immune system that when stimulated can dampen the immune response to an i...